5914 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1744)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2527)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)

More Groups

People
  1. Marc Ladanyi (1327)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (120)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (263)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (758)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5914)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas thymomas
    Meeting Abstract

    Girard, N.; Shen, R.; Guo, T.; Zakowski, M. F.; Heguy, A.; Riely, G. J.; Huang, J.; Lau, C.; Lash, A.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • BRD4-NUT fusion oncogene analysis by RT PCR in sinonasal undifferentiated carcinoma (SNUC) and other aggressive primary sinonasal malignancies: A study of 15 cases
    Meeting Abstract

    Garcia, J. J.; Nafa, K.; Carlson, D. L.; Barnes, E. L.; Seethala, R. R.; Ladanyi, M.
    Modern Pathology (2009)

    Fulltext@MSK | Save
  • Dendritic cells protect against liver-ischemia reperfusion via a Tlr9 and Il-10-dependent mechanism
    Meeting Abstract

    Bamboat, Z. M.; Ocuin, L. M.; Balachandran, V. P.; Obaid, H.; DeMatteo, R. P.
    Hepatology (2009)

    Fulltext@MSK | Save
  • Melanotic XP11 translocation renal cancer: A distinctive neoplasm with overlapping features of pecoma, carcinoma, and melanoma
    Meeting Abstract

    Argani, P.; Aulmann, S.; Karanjawala, Z.; Fraser, R.; Ladanyi, M.; Rodriguez, M.
    Modern Pathology (2009)

    Fulltext@MSK | Save
  • Melanotic Xp11 translocation renal cancers a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma
    Journal Article

    Argani, P.; Aulmann, S.; Karanjawala, Z.; Fraser, R. B.; Ladanyi, M.; Rodriguez, M. M.
    American Journal of Surgical Pathology (2009)

    Fulltext@MSK | Save
  • Improved detection of the EGFR T790M mutation in lung cancer patients with acquired resistance to EGFR TKIs using a locked nucleic acid-based approach
    Meeting Abstract

    Arcila, M. E.; Nafa, K.; Oxnard, G.; Miller, V.; Ladanyi, M.
    Journal of Molecular Diagnostics (2009)

    Fulltext@MSK | Save
  • Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib
    Journal Article

    Zakowski, M. F.; Hussain, S.; Pao, W.; Ladanyi, M.; Ginsberg, M. S.; Heelan, R.; Miller, V. A.; Rusch, V. W.; Kris, M. G.
    Archives of Pathology & Laboratory Medicine (2009)

    Fulltext@MSK | Save
  • Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation
    Journal Article

    Yu, J.; Venstrom, J. M.; Liu, X. R.; Pring, J.; Hasan, R. S.; O'Reilly, R. J.; Hsu, K. C.
    Blood (2009)

    Fulltext@MSK | Save
  • Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells
    Journal Article

    Wang, Y.; Fiskus, W.; Chong, D. G.; Buckley, K. M.; Natarajan, K.; Rao, R.; Joshi, A.; Balusu, R.; Koul, S.; Chen, J.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma
    Journal Article

    Venstrom, J. M.; Zheng, J.; Noor, N.; Danis, K. E.; Yeh, A. W.; Cheung, I. Y.; Dupont, B.; O'Reilly, R. J.; Cheung, N. K. V.; Hsu, K. C.
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save